Study About Lymphocytes Change During Menstrual Cycle in Women of Child-bearing Age

NCT ID: NCT02951832

Last Updated: 2017-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-31

Study Completion Date

2017-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are going to select the normal child-bearing period women as the study subjects and draw their peripheral blood to observe and analyze the change of quantity and percentage of lymphocyte subsets along with the change of menstrual cycle.

Recording their BMI\\menstrual history\\and childbearing history, the investigators would select 300 healthy women in 6 different age groups which are aged 20-24, aged 25-29, aged 30-34, aged35-39, aged 40-44 and aged 45-49, then draw 1-2 ml blood form their peripheral vein (adding EDTA for anti-coagulation). The investigators are going to perform routine examination on the blood samples and detect T\\B\\NK lymphocyte through flow cytometry (FCM), thus calculating the absolute number of every species of lymphocyte. The investigators make assessment for the cellular immune function of the women during child-bearing period via comparing distinction in percentage and absolute number of every lymphocyte subset among reproductive-age women in different ages.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphocyte Subsets in Women of Child-bearing Age

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

observational group

Observational Study about Lymphocytes Change during Menstrual Cycle in Women of Child-bearing Age

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women aged 20-49;
* Having a regular menstrual cycle of which the menstrual period is between day 3-7, and the period between day 25-35;
* Excluding internal and surgical disease (after having variety of physical examination such as electrocardiogram/hepatic and renal function/blood routine and urine routine).

Exclusion Criteria

* Having experienced severe allergies, trauma history and/or operation history within 3 months;
* With a history of mental illness and/or family history of mental illness;
* Limb disabled;
* Taking medicine within one month;
* Suffering major events or having mood swings.
Minimum Eligible Age

20 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai First Maternity and Infant Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shihua Bao

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tao Duan

Role: STUDY_CHAIR

Shanghai First Maternity and Infant Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai first Maternity and Infant health hospital, Tong Ji University

Shanghai, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yan Yan

Role: CONTACT

86-18964213238

Shihua Bao

Role: CONTACT

86-021-20261000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shihua Bao, PhD

Role: primary

86-21-20261430 ext. 2012

Yan Yan, Master

Role: backup

86-21-20261430 ext. 2012

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ShanghaiFMIH-RI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Natural History Study for BEN
NCT00059423 COMPLETED
Inflammatory Response to OMT
NCT06820684 COMPLETED NA